[1] |
王会奇, 方伯言, 刘翠, 等. 帕金森病康复治疗研究进展[J]. 中国康复理论与实践, 2018, 24(7):763-766.
|
[2] |
黄佩玲, 方伯言, 公维军. 帕金森病吞咽障碍的研究进展[J]. 中国康复理论与实践, 2018, 24(7):787-790.
|
[3] |
裴广盈, 闫天翼, 方伯言, 等. 神经反馈技术在帕金森病治疗中的应用进展[J]. 中国康复理论与实践, 2018, 24(12):1413-1416.
|
[4] |
王瑞丹, 黄佩玲, 公维军, 等. 虚拟现实技术在帕金森病冻结步态康复中的应用进展[J]. 中国康复理论与实践, 2018, 24(7):791-794.
|
[5] |
中华医学会神经病学分会神经康复学组, 中国微循环学会神经变性病专业委员会康复学组, 中国康复医学会帕金森病与运动障碍康复专业委员会. 帕金森病康复中国专家共识[J]. 中国康复理论与实践, 2018, 24(7):745-752.
|
[6] |
Keus S H J, Munneke M, Graziano M, et al. European Physiotherapy Guideline for Parkinson's Disease[S]. Netherlands: KNGF/ParkinsonNet, 2014.
|
[7] |
Nieuwboer A, De Weerdt W, Dom R, et al. Development of an activity scale for individuals with advanced Parkinson disease: reliability and "on-off" variability[J]. Phys Ther, 2000, 80(11):1087-1096.
pmid: 11046196
|
[8] |
Whitney S L, Wrisley D M, Marchetti G F, et al. Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the Five-Times-Sit-to-Stand Test[J]. Phys Ther, 2005, 85(10):1034-1045.
pmid: 16180952
|
[9] |
King L, Horak F. On the Mini-BESTest: scoring and the reporting of total scores[J]. Phys Ther, 2013, 93(4):571-575.
doi: 10.2522/ptj.2013.93.4.571
|
[10] |
Benka Wallén M, Sorjonen K, Löfgren N, et al. Structural validity of the Mini-Balance Evaluation Systems Test (Mini-BESTest) in people with mild to moderate Parkinson disease[J]. Phys Ther, 2016, 96(11):1799-1806.
doi: 10.2522/ptj.20150334
|
[11] |
Morris S, Morris M E, Iansek R. Reliability of measurements obtained with the Timed “Up & Go” Test in people with Parkinson disease[J]. Phys Ther, 2001, 81(2):810-818.
pmid: 11175678
|
[12] |
Penko A L, Barkley J E, Koop M M, et al. Borg Scale is valid for ratings of perceived exertion for individuals with Parkinson's disease[J]. Int J Exerc Sci, 2017, 10(1):76-86.
|
[13] |
Jacobs J V, Horak F B, Van Tran K, et al. An alternative clinical postural stability test for patients with Parkinson's disease[J]. J Neurol, 2006, 253(11):1404-1413.
pmid: 16788773
|
[14] |
John S, Moorthy R K, Sebastian T, et al. Evaluation of hand function in healthy individuals and patients undergoing uninstrumented central corpectomy for cervical spondylotic myelopathy using Nine-hole Peg Test[J]. Neurol India, 2017, 65(6):1025-1030.
doi: 10.4103/neuroindia.NI_12_17
|
[15] |
Luo W, Gui X H, Wang B, et al. Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39)[J]. J Zhejiang Univ Sci B, 2010, 11(7):531-538.
doi: 10.1631/jzus.B0900380
|
[16] |
Opara J A, Brola W, Leonardi M, et al. Quality of life in Parkinson's disease[J]. J Med Life, 2012, 5(4):375-381.
pmid: 23346238
|
[17] |
Van der Eijk M, Faber M J, Ummels I, et al. Patient-centeredness in PD care: development and validation of a patient experience questionnaire[J]. Parkinsonism Relat Disord, 2012, 18(9):1011-1016.
doi: 10.1016/j.parkreldis.2012.05.017
|
[18] |
Duncan R P, Leddy A L, Dibble L E, et al. Accuracy of fall prediction in Parkinson disease: six-month and 12-month propective analyses[J]. Parkinsons Dis, 2012: 237673.
|
[19] |
Alves G, Wentzel-Larsen T, Aarsland D, et al. Progression of motor impairment and disability in Parkinson disease: a population-based study[J]. Neurology, 2005, 65(9):1436-1441.
doi: 10.1212/01.wnl.0000183359.50822.f2
|
[20] |
Muslimovic D, Schmand B, Speelman J D, et al. Course of cognitive decline in Parkinson’s disease: a meta-analysis[J]. J Int Neuropsychol Soc, 2007, 13(6):920-932.
doi: 10.1017/S1355617707071160
|
[21] |
Post B, Speelman J D, de Haan R J. Clinical heterogeneity in newly diagnosed Parkinson’s disease[J]. J Neurol, 2008, 255(5):716-722.
doi: 10.1007/s00415-008-0782-1
|
[22] |
WHO. International Classification of Functioning, Disability and Health (ICF)[EB/OL]. [2019- 02- 22] www who int/classifications/icf/en/index html
|
[23] |
邱卓英, 励建安, 吴弦光. ICF核心分类组合临床实践手册[M]. 北京: 人民军医出版社, 2013.
|
[24] |
邱卓英, 张爱民. 《国际功能、残疾和健康分类》应用指导(一)[J]. 中国康复理论与实践, 2003, 9(1):31-32.
|
[25] |
Goetz C G, Tilley B C, Shaftman S R, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results[J]. Mov Disord, 2008, 23(15):2129-2170.
doi: 10.1002/mds.22340
|
[26] |
Hoehn M M, Yahr M D. Parkinsonism: onset, progression and mortality, 1967[J]. Neurology, 2001, 57(10 Suppl 3):S11-S26.
|
[27] |
Rochester L, Nieuwboer A, Lord S. Physiotherapy for Parkinson’s disease: defining evidence with a framework for intervention[J]. Neurodegen Dis Manage, 2011, 1:57-65.
doi: 10.2217/nmt.11.1
|
[28] |
Garcia-Ruiz P J, Del V J, Femandez I M, et al. What factors influence motor complications in Parkinson disease?: a 10-year prospective study[J]. Clin Neuropharmacol, 2012, 35(1):1-5.
doi: 10.1097/WNF.0b013e31823dec73
|
[29] |
Litvan I, Aarsland D, Adler C H, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI[J]. Mov Disord, 2011, 26(10):1814-1824.
doi: 10.1002/mds.v26.10
|
[30] |
侯媌媌, 汤荟冬, 陈生弟. 帕金森病认知功能障碍筛查工具剖析[J]. 内科理论与实践, 2015, 10(2):148-151.
|